All articles

NAD+ Injections: Benefits, Safety & Side Effects

Reading time:

9 min

Published on

Updated on

Longevity

Ready to transform your health?

Ready to transform your health?

Get expert guidance and a personalized care plan designed around you.

Key Takeaways

  • NAD+ is an essential molecule in every cell that supports energy production, DNA repair, and immune function, but levels decline with age.

  • Most human research has studied oral precursors (NMN, NR), not direct NAD+ injections. Human evidence for injections specifically is still limited.

  • Animal studies suggest NAD+ supplementation may support heart, nerve, and lung tissue health, but these findings have not been confirmed in human trials.

  • Subcutaneous NAD+ injections absorb gradually and can be self-administered at home, while IV therapy requires a clinical setting.

  • Side effects may include nausea, headaches, chest tightness, and tingling. Always consult a licensed provider before starting NAD+ therapy.

You have probably heard a lot about NAD+ lately, and with good reason. Although our bodies produce this essential molecule on their own, our natural levels tend to drop as we get older.

Depleted levels of NAD+ are not just a byproduct of aging. They are also linked to chronic inflammation, diabetes, and various conditions associated with growing older. As a result, researchers are studying whether boosting NAD+ can slow decline and promote longevity (1,2).

While NAD+ injections do show promise in boosting cellular energy, possibly delaying certain aspects of aging, and even treating disease, evidence in humans is still lacking (3). Most human clinical trials have not tested direct NAD+ injections. Instead, most human clinical research has focused on oral 'precursors', compounds like NMN, NR, niacinamide, and niacin. These supplements provide the essential raw materials the body needs to synthesize its own supply of NAD+. (4).

Adding to the confusion, direct NAD+ injections have yielded encouraging results in animal models, but human research remains in its early stages (3). Without robust clinical data, it is hard to determine whether direct NAD+ injections are helpful, neutral, or potentially harmful.

However, because NAD+ is natural and has real benefits from our own internal production, researchers are continuing to study this fascinating molecule. Here is a look at what we currently know about NAD+ injections, the potential benefits, and key considerations to keep in mind.

Key Takeaways

  • NAD+ is an essential molecule in every cell that supports energy production, DNA repair, and immune function, but levels decline with age.

  • Most human research has studied oral precursors (NMN, NR), not direct NAD+ injections. Human evidence for injections specifically is still limited.

  • Animal studies suggest NAD+ supplementation may support heart, nerve, and lung tissue health, but these findings have not been confirmed in human trials.

  • Subcutaneous NAD+ injections absorb gradually and can be self-administered at home, while IV therapy requires a clinical setting.

  • Side effects may include nausea, headaches, chest tightness, and tingling. Always consult a licensed provider before starting NAD+ therapy.

You have probably heard a lot about NAD+ lately, and with good reason. Although our bodies produce this essential molecule on their own, our natural levels tend to drop as we get older.

Depleted levels of NAD+ are not just a byproduct of aging. They are also linked to chronic inflammation, diabetes, and various conditions associated with growing older. As a result, researchers are studying whether boosting NAD+ can slow decline and promote longevity (1,2).

While NAD+ injections do show promise in boosting cellular energy, possibly delaying certain aspects of aging, and even treating disease, evidence in humans is still lacking (3). Most human clinical trials have not tested direct NAD+ injections. Instead, most human clinical research has focused on oral 'precursors', compounds like NMN, NR, niacinamide, and niacin. These supplements provide the essential raw materials the body needs to synthesize its own supply of NAD+. (4).

Adding to the confusion, direct NAD+ injections have yielded encouraging results in animal models, but human research remains in its early stages (3). Without robust clinical data, it is hard to determine whether direct NAD+ injections are helpful, neutral, or potentially harmful.

However, because NAD+ is natural and has real benefits from our own internal production, researchers are continuing to study this fascinating molecule. Here is a look at what we currently know about NAD+ injections, the potential benefits, and key considerations to keep in mind.

What Are NAD+ Injections?

Nicotinamide adenine dinucleotide (NAD+) is an essential molecule and coenzyme found in every single cell in your body. Think of it as a power source for our cells that helps drive energy production, DNA repair, immune function, and healthy gene expression (1,5). While our bodies naturally make NAD+ using the amino acid tryptophan, we can also produce it from precursor nutrients like NMN, NR, NAM, and NA (6).

Providing NAD+ directly or through precursors is complex due to how this molecule is produced and metabolized. NAD+ is created through three major pathways in the body, using tryptophan, nicotinic acid, or nicotinamide (7). Depending on the tissue type and individual factors, these pathways vary in metabolism and production efficiency. While animal and some human studies suggest potential benefits of externally supplementing with NAD+ or its precursors, scientists still face challenges in understanding how effectively our bodies utilize these supplements (8,9).

Key challenges include:

  • Enzyme variations: NAD+ and its precursors are synthesized and cleared in different ways across tissues, ages, and individuals. Thus, it’s possible that external supplementation may not yield uniform levels in each person (10). In addition, when one takes oral precursors such as NR or NMN, individual variations in metabolism and the gut microbiome may play large roles in determining NAD+ levels (11). 

  • NAD+ clearance: One study on IV NAD+ infusion showed that plasma NAD+ levels did not rise until after 2 hours of infusion time, as the body cleared NAD+ rapidly from plasma initially. Levels eventually reached a maximum of about 400% above baseline, but required 6 hours of infusion. While no significant adverse events occurred, researchers observed signs of liver enzyme strain from the large load of NAD+ (12). Another study showed rapid clearance of IV NR and NMN from the body (11).

  • Large molecule size: Some researchers believe the NAD+ molecule is simply too large to cross most cell membranes intact. Although high plasma levels occur during infusions, researchers cannot confirm that NAD+ reaches the cells directly. It may undergo rapid breakdown into smaller precursors via enzymes before entering cells (11-13).

  • Clinical relevance: Research shows that while NAD+ might cross membranes in certain contexts, it may not reliably impact DNA repair or offer confirmed clinical improvements (14).

What Are NAD+ Injections?

Nicotinamide adenine dinucleotide (NAD+) is an essential molecule and coenzyme found in every single cell in your body. Think of it as a power source for our cells that helps drive energy production, DNA repair, immune function, and healthy gene expression (1,5). While our bodies naturally make NAD+ using the amino acid tryptophan, we can also produce it from precursor nutrients like NMN, NR, NAM, and NA (6).

Providing NAD+ directly or through precursors is complex due to how this molecule is produced and metabolized. NAD+ is created through three major pathways in the body, using tryptophan, nicotinic acid, or nicotinamide (7). Depending on the tissue type and individual factors, these pathways vary in metabolism and production efficiency. While animal and some human studies suggest potential benefits of externally supplementing with NAD+ or its precursors, scientists still face challenges in understanding how effectively our bodies utilize these supplements (8,9).

Key challenges include:

  • Enzyme variations: NAD+ and its precursors are synthesized and cleared in different ways across tissues, ages, and individuals. Thus, it’s possible that external supplementation may not yield uniform levels in each person (10). In addition, when one takes oral precursors such as NR or NMN, individual variations in metabolism and the gut microbiome may play large roles in determining NAD+ levels (11). 

  • NAD+ clearance: One study on IV NAD+ infusion showed that plasma NAD+ levels did not rise until after 2 hours of infusion time, as the body cleared NAD+ rapidly from plasma initially. Levels eventually reached a maximum of about 400% above baseline, but required 6 hours of infusion. While no significant adverse events occurred, researchers observed signs of liver enzyme strain from the large load of NAD+ (12). Another study showed rapid clearance of IV NR and NMN from the body (11).

  • Large molecule size: Some researchers believe the NAD+ molecule is simply too large to cross most cell membranes intact. Although high plasma levels occur during infusions, researchers cannot confirm that NAD+ reaches the cells directly. It may undergo rapid breakdown into smaller precursors via enzymes before entering cells (11-13).

  • Clinical relevance: Research shows that while NAD+ might cross membranes in certain contexts, it may not reliably impact DNA repair or offer confirmed clinical improvements (14).

Potential Benefits of Boosting NAD+

Even with limited human research on direct injections, NAD+ plays a fundamental role in physiological health. Low levels are linked to metabolic conditions, brain and eye health challenges, and chronic physical stress (1). And, while direct NAD+ injections have been less studied, there has been a bit more human research on boosting NAD+ levels through taking precursors. So far, human studies suggest that taking NAD+ precursors may help (9):

  • Prevent nonmelanoma skin cancers

  • Reduce the risk of acute kidney injury in high risk individuals

  • Modestly lower blood pressure and cholesterol in individuals with overweight or obesity

  • Suppress inflammation in patients with Parkinson's disease

  • Lower inflammatory markers during active infections such as SARS-CoV-2

Direct human research on NAD+ injections remains limited, but animal studies suggest direct supplementation may help (15-17):

  • Decrease heart muscle damage following a heart attack

  • Support nerve health and cellular protection

  • Protect lung tissue from damage caused by cigarette smoke

Potential Benefits of Boosting NAD+

Even with limited human research on direct injections, NAD+ plays a fundamental role in physiological health. Low levels are linked to metabolic conditions, brain and eye health challenges, and chronic physical stress (1). And, while direct NAD+ injections have been less studied, there has been a bit more human research on boosting NAD+ levels through taking precursors. So far, human studies suggest that taking NAD+ precursors may help (9):

  • Prevent nonmelanoma skin cancers

  • Reduce the risk of acute kidney injury in high risk individuals

  • Modestly lower blood pressure and cholesterol in individuals with overweight or obesity

  • Suppress inflammation in patients with Parkinson's disease

  • Lower inflammatory markers during active infections such as SARS-CoV-2

Direct human research on NAD+ injections remains limited, but animal studies suggest direct supplementation may help (15-17):

  • Decrease heart muscle damage following a heart attack

  • Support nerve health and cellular protection

  • Protect lung tissue from damage caused by cigarette smoke

NAD+ Injections vs. IV Therapy: What is the Difference?

Because data on direct outcomes in humans is limited, comparing subcutaneous injections (SQ) and intravenous (IV) therapy relies primarily on general pharmacological principles (18, 19).

  • Administration: IV therapy delivers medication directly into a vein and requires administration by a healthcare professional in a clinical setting. Subcutaneous  injections deposit medication into the fatty layer directly beneath the skin, making them easy to self administer at home.

  • Absorption and Speed: Because IV injections go directly into the bloodstream, 100% of the dose enters systemic circulation instantly for the fastest onset. SQ injections absorb slowly from tissue into circulation, creating a gradual, steady release.

  • Bioavailability: IV medications offer 100% bioavailability because none of the dose is lost during absorption (20). SQ medications have slightly lower overall bioavailability due to gradual tissue absorption, but they provide longer lasting, predictable systemic levels.

  • Metabolism: Both delivery methods bypass first pass metabolism in the liver and stomach that occurs with oral pills. Once in circulation, the liver and kidneys clear and process both methods similarly.

NAD+ Injections vs. IV Therapy: What is the Difference?

Because data on direct outcomes in humans is limited, comparing subcutaneous injections (SQ) and intravenous (IV) therapy relies primarily on general pharmacological principles (18, 19).

  • Administration: IV therapy delivers medication directly into a vein and requires administration by a healthcare professional in a clinical setting. Subcutaneous  injections deposit medication into the fatty layer directly beneath the skin, making them easy to self administer at home.

  • Absorption and Speed: Because IV injections go directly into the bloodstream, 100% of the dose enters systemic circulation instantly for the fastest onset. SQ injections absorb slowly from tissue into circulation, creating a gradual, steady release.

  • Bioavailability: IV medications offer 100% bioavailability because none of the dose is lost during absorption (20). SQ medications have slightly lower overall bioavailability due to gradual tissue absorption, but they provide longer lasting, predictable systemic levels.

  • Metabolism: Both delivery methods bypass first pass metabolism in the liver and stomach that occurs with oral pills. Once in circulation, the liver and kidneys clear and process both methods similarly.

Potential Side Effects

Individual responses to NAD+ administration vary. Based on existing animal studies and limited human trials using IV NAD+ or high dose precursors, reported side effects include:

  • Cardiovascular and Muscle Symptoms: Chest tightness, rapid heart rate, and localized muscle cramping (21).

  • Gastrointestinal Distress: Abdominal cramping, nausea, and intestinal discomfort (7, 21, 22)

  • Neurological Effects: Temporary headaches, dizziness, fatigue, anxiety, insomnia, and localized tingling sensations in the jaw, tongue, or arms (22).

  • Metabolic Findings: Preclinical models using high dosages have noted potential liver strain, methyl group depletion, and changes in glucose sensitivity (7, 12, 23).

How Subcutaneous NAD+ Injection Therapy Works

When prescribed, NAD+ is most commonly administered as a subcutaneous injection into the tissue of the abdomen or outer thigh. Patients may experience mild discomfort or minor localized reactions at the injection site (24). Dosages should always be determined and monitored by a licensed healthcare provider.

Peptide and Coenzyme Safety: Key Considerations

Peptides and specialized coenzymes have more recently gained significant popularity in wellness care (25). While regulatory bodies like the FDA approved nine new peptide therapies in a single year (2023) (26), taking appropriate precautions remains essential:

  1. Watch for Allergic Reactions: Like any therapy, injected compounds can trigger immune responses. Seek immediate medical care if you experience hives, shortness of breath, chest pain, or severe dizziness. Allergies can develop over time even after previous uneventful uses (27-29).

  2. Recognize Animal vs. Human Findings: Results from animal models do not guarantee identical effects or safety profiles in humans. Always discuss investigational therapies with a healthcare professional before starting (30).

  3. Verify Product Sourcing: It’s a good idea to avoid unregulated online vendors. Ensure formulations come from accredited compounding pharmacies that provide a Certificate of Analysis (CoA) verifying 99%+ purity and testing for contaminants (31).

  4. Monitor Injection Sites: Sometimes, mild, temporary redness can occur. However, persistent swelling, hardening, or worsening pain over time requires medical evaluation to rule out infection or hypersensitivity (32).

Always consult a qualified healthcare provider before starting NAD+ or peptide-based therapies. If you are interested in exploring whether these options are appropriate for you, check your eligibility here: Mochi Health Eligibility.

FAQs

What are NAD+ injections?

NAD+ injections deliver nicotinamide adenine dinucleotide directly into the body through a subcutaneous injection. Unlike oral supplements, injections bypass digestion for more direct absorption. 

What are the side effects of NAD+ injections?

Reported side effects from NAD+ or high-dose precursor studies include nausea, abdominal cramping, chest tightness, headaches, dizziness, and localized tingling. In preclinical studies, high dosages have also been associated with liver enzyme changes and shifts in glucose sensitivity.

Are NAD+ injections safe?

Human safety data on direct NAD+ injections is limited. While no significant adverse events were reported in small IV infusion studies, researchers noted signs of liver strain at high doses. Formulations should come from accredited compounding pharmacies with verified purity testing.

How are NAD+ injections different from IV NAD+ therapy?

IV therapy delivers NAD+ directly into the bloodstream for immediate 100% bioavailability but requires a clinical setting and can take several hours. Subcutaneous injections absorb gradually for steadier levels and can be done at home. Both bypass the first-pass liver metabolism that occurs with oral supplements.


References:

  1. Alegre, G. F. S., & Pastore, G. M. (2023). NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR): Potential dietary contribution to health. Current Nutrition Reports, 12(3), 445–464. https://pmc.ncbi.nlm.nih.gov/articles/PMC10240123/ 

  2. Shade, C. (2020). The science behind NMN–A stable, reliable NAD+ activator and anti-aging molecule. Integrative Medicine: A Clinician's Journal, 19(1), 12–14. https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909/ 

  3. Gallagher, C., & Emmanuel, O. O. (2026). NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews, 116, Article 103057. https://www.sciencedirect.com/science/article/pii/S1568163726000498 

  4. Bloomer, R. J., Timmcke, J. Q., & Ramanathan, C. (2025). Use of the dietary supplements NR and NMN to increase nicotinamide adenine dinucleotide, impact mitochondrial function, and improve metabolic health. Clinical Bioenergetics, 1(2), Article 9. https://doi.org/10.3390/clinbioenerg1020009 

  5. Braidy, N., & Liu, Y. (2020). NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Experimental Gerontology, 132, Article 110831. https://www.sciencedirect.com/science/article/abs/pii/S0531556519307582 

  6. Davis, I., & Liu, A. (2015). What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics? Expert Review of Neurotherapeutics, 15(7), 719–721. https://pmc.ncbi.nlm.nih.gov/articles/PMC4482796/ 

  7. She, J., Sheng, R., & Qin, Z.-H. (2021). Pharmacology and potential implications of nicotinamide adenine dinucleotide precursors. Aging and Disease, 12(8), 1879–1897. https://pmc.ncbi.nlm.nih.gov/articles/PMC8612620/ 

  8. Radenkovic, D., Reason, & Verdin, E. (2020). Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals, 13(9), 247. https://www.mdpi.com/1424-8247/13/9/247

  9. Bhasin, S., Seals, D., Migaud, M., Musi, N., & Baur, J. A. (2023). Nicotinamide adenine dinucleotide in aging biology: Potential applications and many unknowns. Endocrine Reviews, 44(6), 1047–1073. https://doi.org/10.1210/endrev/bnad019 

  10. Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020). NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy, 5(1), Article 227. https://doi.org/10.1038/s41392-020-00311-7 

  11. Yaku, K., Palikhe, S., Iqbal, T., Hayat, F., Watanabe, Y., Fujisaka, S., Izumi, H., Yoshida, T., Karim, M., Uchida, H., Nawaz, A., Tobe, K., Mori, H., Migaud, M. E., & Nakagawa, T. (2025). Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances, 11(12), Article eadr1538. https://doi.org/10.1126/sciadv.adr1538 

  12. Grant, R., Berg, J., Mestayer, R., Braidy, N., Bennett, J., Broom, S., & Watson, J. (2019). A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11, Article 257. https://doi.org/10.3389/fnagi.2019.00257 

  13. Nikiforov, A., Dölle, C., Niere, M., & Ziegler, M. (2011). Pathways and subcellular compartmentation of NAD biosynthesis in human cells: From entry of extracellular precursors to mitochondrial NAD generation. Journal of Biological Chemistry, 286(24), 21767–21778. https://doi.org/10.1074/jbc.M110.213298

  14. Pittelli, M., Felici, R., Pitozzi, V., Giovannelli, L., Bigagli, E., Cialdai, F., ... & Chiarugi, A. (2011). Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Molecular pharmacology, 80(6), 1136-1146.  https://molpharm.aspetjournals.org/article/S0026-895X(24)03359-5/abstract

  15. Zhang, Y., Wang, B., Fu, X., Guan, S., Han, W., Zhang, J., Gan, Q., Fang, W., Ying, W., & Qu, X. (2016). Exogenous NAD+ administration significantly protects against myocardial ischemia/reperfusion injury in rat model. American Journal of Translational Research, 8(8), 3342–3350. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009387/ 

  16. Takaso, Y., Noda, M., Hattori, T., Roboon, J., Hatano, M., Sugimoto, H., Brenner, C., Yamamoto, Y., Okamoto, H., Higashida, H., Ito, M., Yoshizaki, T., & Hori, O. (2020). Deletion of CD38 and supplementation of NAD+ attenuate axon degeneration in a mouse facial nerve axotomy model. Scientific Reports, 10(1), Article 17795. https://doi.org/10.1038/s41598-020-73984-3 

  17. Slama, N., Abdellatif, A., Bahria, K., Gasmi, S., Khames, M., Hadji, A., Birkmayer, G., Oumouna, M., Amrani, Y., & Benachour, K. (2024). NADH intraperitoneal injection prevents lung inflammation in a BALB/C mice model of cigarette smoke-induced chronic obstructive pulmonary disease. Cells, 13(10), Article 881. https://doi.org/10.3390/cells13100881 

  18. Bittner, B., Richter, W., & Schmidt, J. (2018). Subcutaneous administration of biotherapeutics: An overview of current challenges and opportunities. BioDrugs, 32(5), 425–440. https://doi.org/10.1007/s40259-018-0295-0 

  19. Jin, J.-F., Zhu, L.-L., Chen, M., Xu, H.-M., Wang, H.-F., Feng, X.-Q., Zhu, X.-P., & Zhou, Q. (2015). The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Preference and Adherence, 9, 923–942. https://doi.org/10.2147/PPA.S87271 

  20. Price, G., & Patel, D. A. (2023). Drug bioavailability. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557852/

  21. Reyna, K., Heinzen, G., Patel, N., Ritter, M., Siojo, A., Legere, H., & Pojednic, R. (2026). Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): A retrospective tolerability pilot study in a real-world setting. Frontiers in Aging, 7, Article 1652582. https://doi.org/10.3389/fragi.2026.1652582 

  22. Gindri, I. de M., Ferrari, G., Pinto, L. P. S., Bicca, J., dos Santos, I. K., Dallacosta, D., & Roesler, C. R. de M. (2024). Evaluation of safety and effectiveness of NAD in different clinical conditions: A systematic review. American Journal of Physiology-Endocrinology and Metabolism, 326(4), E417–E427. https://doi.org/10.1152/ajpendo.00242.2023 

  23. Hwang, E. S., & Song, S. B. (2020). Possible adverse effects of high-dose nicotinamide: Mechanisms and safety assessment. Biomolecules, 10(5), Article 687. https://doi.org/10.3390/biom10050687 

  24. Kashat, E. (2026, June 8). NAD injections: How they work and what providers should know. MediVera Compounding Pharmacy. https://mediverarx.com/nad-injections-guide/ 

  25. Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: Current applications and future directions. Signal Transduction and Targeted Therapy, 7(1), Article 48. https://doi.org/10.1038/s41392-022-00904-4 

  26. de la Torre, B. G., & Albericio, F. (2024). The pharmaceutical industry in 2023: An analysis of FDA drug approvals from the perspective of molecules. Molecules, 29(3), Article 585. https://doi.org/10.3390/molecules29030585 

  27. Shankar, G., Arkin, S., Cocea, L., Devanarayan, V., Kirshner, S., Kromminga, A., Quarmby, V., Richards, S., Schneider, C. K., Subramanyam, M., Swanson, S., Verthelyi, D., & Yim, S. (2014). Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides—Harmonized terminology and tactical recommendations. The AAPS Journal, 16(4), 658–673. https://doi.org/10.1208/s12248-014-9599-2 

  28. Chu, M.-T., Chang, W.-C., Pao, S.-C., & Hung, S.-I. (2023). Delayed drug hypersensitivity reactions: Molecular recognition, genetic susceptibility, and immune mediators. Biomedicines, 11(1), Article 177. https://doi.org/10.3390/biomedicines11010177 

  29. Yaneva, M., Handjieva-Darlenska, T., Kazandjieva, J., & Darlenski, R. (2023). Delayed type hypersensitivity injection site reaction and tolerance induction to liraglutide for the treatment of obesity. JAAD Case Reports, 38, 100–101. https://doi.org/10.1016/j.jdcr.2023.06.010 

  30. Pound, P., & Bracken, M. B. (2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research? BMJ, 348, g3387. https://doi.org/10.1136/bmj.g3387 

  31. U.S. Food and Drug Administration. (2026, May 14). Bulk drug substances used in compounding under Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act 

  32. Freibott, C. E., Phillips, K. T., Anderson, B. J., Stewart, C., Liebschutz, J. M., & Stein, M. D. (2022). Under the skin: The relationship between subcutaneous injection and skin infections among people who inject drugs. Journal of Addiction Medicine, 16(2), 164–168. https://doi.org/10.1097/ADM.0000000000000844


Disclaimer: This article is for educational purposes only and should not be considered medical advice. The information provided does not constitute recommendations for treatment. Always consult with your healthcare provider about your specific situation, symptoms, and treatment options.

For iOS & Android

Start with care designed for you

Start with care designed for you

What can we help you with?

What can we help you with?

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

Personalized care for long-term wellness

Small wins add up to big transformations. Mochi reminds us to focus on what’s good and use it to build the life we envision.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.